Evidence map›Paper›PMID 31024562›Full record

ArticleFrontiers in immunology2019

Chronic HIV-1 Infection Alters the Cellular Distribution of FcγRIIIa and the Functional Consequence of the FcγRIIIa-F158V Variant.

Ntando G Phaahla, Ria Lassaunière, Bianca Da Costa Dias, Ziyaad Waja, Neil A Martinson, Caroline T Tiemessen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Terminal Effector CD8 T Cells Defined by an IKZF2Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ntando G PhaahlaCentre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.
Ria LassaunièreCentre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.
Bianca Da Costa DiasCentre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.
Ziyaad WajaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Neil A MartinsonPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Caroline T TiemessenCentre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.
University of the Witwatersrand · ZAStatens Serum Institut · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic HIV-infection modulates the expression of Fc gamma receptors (FcγRs) on immune cells and their antibody-dependent effector function capability. Given the increasingly recognized importance of antibody-dependent cellular cytotoxicity (ADCC) in HIV-specific immunity, we investigated the cellular distribution of FcγRIIIa on cytotoxic lymphocytes-natural killer cells and CD8

Indexed as

HIV-1AdultAntibody-Dependent Cell CytotoxicityCase-Control StudiesCD8-Positive T-LymphocytesCohort StudiesFemaleGenetic VariationHIV InfectionsHumansImmunogenetic PhenomenaKiller Cells, NaturalLymphocyte SubsetsMaleMiddle AgedReceptors, IgGFCGR3A protein, humanReceptors, IgGantibody-dependent cellular cytotoxicityCD8 T cellsFc gamma receptorHIVinfectionNK cellspolymorphism

Identifiers

PMID31024562
PMCPMC6467939
OpenAlexW2938555133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.